@Cajo_79_Silva @grod86 @VinnyLaw these "mercenaries of profit" lost hundreds of milions on $APLS $PRTA $SRPT $TECX $HLVX last couple of years.
They are just guessing and risking. Entering at low price makes their decision a bit easier. We will see who sold out at a loss, what's the institutional ownership after this q.
$XOMA closes tender offer for $HLVX
https://www.globenewswire.com/news-release/2025/09/17/3151655/7281/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-for-HilleVax-Inc.html
• Following the closing of the tender offer, XOMA acquired HLVX
• HLVX shareholders will receive $1.95 and a CVR per share.
$HLVX NASDAQ Equity Corporate Actions Alert # 2025 - 503
Information Regarding the Tender Offer of HilleVax, Inc. (HLVX)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-503
The tender offer by $XOMA to acquire all of the outstanding common stock of HilleVax, Inc. (HLVX) is scheduled to expire one minute after 11:59 p.m. ET, on September 15, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on September 17, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on September 16, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (September 17) and will be suspended effective September 18, 2025.
Tender offer: HLVX shareholders will receive $1.95 plus one non-transferable contingent value right for each share held. If you own 1000 HLVX, you will receive $1950 plus 1000 CVRs.
$HLVX Great piece that accurately captures HLVX's current position. So if you want to refresh your understanding of HLVX or learn about HLVX for the first time, this is essential reading. https://beyondspx.com/quote/HLVX/analysis/hillevax-hlvx-a-strategic-pivot-towards-acquisition-and-contingent-value
$VXRT at one time $HLVX was worth close to 1 billion MC
how is it possible they are still worth more than $VXRT
this is obvious price suppression/manipulation
Busy weekend for $XOMA. Closed on two acquisitions.
1) Acquiring $HLVX for $1.95 per share, plus a CVR. CVR payouts as follows:
• If HLVX clsoing cash is over $102.95m, CVR holders will receive a pro-rata portion of the remaining cash above that.
• 90-100% of any savings from closing of HLVX's Boston office lease obligations.
• 90% of any proceeds XOMA receives in the next 5 yearw from the sale or licensing of HLVX's norovirus vaccine program. Sale or license must occur within the next two years.
Tender offer expected to close in Sept 2025.
2) Acquiring $LVTX for between $1.16 and $1.24 Per Share in Cash, plus CVR. CVR payout as follows:
• 75% of the net proceeds related to LAVA’s two partnered assets
• 75% of any net proceeds from any out license or sale of LAVA’s unpartnered programs.
Tender offer expected to close in Q4 2025.
@ZorTrades this 5.8% stake you mention in $HLVX, I am not seeing this on Dilution Tracker. Where did you get that info?? I may add on this breakout potential trade
🚨 Fresh 13G/13D Filings – Smart Money Moves:
📈 $CTNM – Contineum Therapeutics
RA Capital: Top-tier biotech VC/hedge fund led by Peter Kolchinsky, focused on early-to-mid stage healthcare.
🧬 New 2.12M share stake (9.9% of float) — 100% new
📈 $HLVX – HilleVax
EcoR1 Capital: Biotech specialist hedge fund run by Oleg Nodelman, known for early innovation bets.
💉 New 2.89M share stake (5.8% of float) — 100% new
📈 $ELBM – Electra Battery Materials
Highbridge Capital: Multi-strategy hedge fund founded by Scott Kapnick (ex-Goldman), active in distressed and special sits.
🔋 New 3.59M share stake (9.9% of float) — 100% new
All filed late July 2025.
